Gilead Sciences Stock (NASDAQ: GILD) stock price, news, charts, stock research, profile.
You can purchase shares of Gilead Sciences (NASDAQ:GILD) through any online brokerage.
Other companies in Gilead Sciences’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
Gilead Sciences has a consensus price target of $91.64.
The stock price for Gilead Sciences (NASDAQ: GILD) is $94.35 last updated November 12, 2024 at 6:05 PM EST.
A quarterly cash dividend of 0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on September 27, 2024 to stockholders of record on September 13, 2024.
Gilead Sciences’s Q4 earnings are confirmed for Tuesday, February 4, 2025.
There is no upcoming split for Gilead Sciences.
Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.